Docking-based virtual screening of potential human P2Y12 receptor antagonists

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 5, 2011, Pages 400-408

  Chen, Hua ^a   Dong, Xianchi ^b,c   Zhou, Minyun ^b,c   Shi, Haiming ^a   Luo, Xinping ^a  

^a FUDAN UNIVERSITY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

anti coagulation; homology modeling; P2Y12; virtual screening

Indexed keywords

LIGAND; P2RY12 PROTEIN, HUMAN; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; DRUG EVALUATION, PRECLINICAL; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; SEQUENCE HOMOLOGY, AMINO ACID;

MELEAGRIS GALLOPAVO;

EID: 79955400687     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr023     Document Type: Article

References (53)

1. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002, 8: 1227-1234. (Pubitemid 35373553)
2. Jackson SP, Nesbitt WS and Kulkarni S. Signaling events underlying thrombus formation. J Thromb Haemost 2003, 1: 1602-1612.
3. Davies MJ and Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984, 310: 1137-1140. (Pubitemid 14135387)
4. Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962, 194: 927-929.
5. Cattaneo M, Lombardi R, Zighetti ML, Gachet C, Ohlmann P, Cazenave JP and Mannucci PM. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. J Thromb Haemost 1997, 77: 986-990. (Pubitemid 27239127)
6. Mills DC. ADP receptors on platelets. J Thromb Haemost 1996, 76: 835-856. (Pubitemid 27013617)
7. Savi P, Beauverger P, Labouret C, Delfaud M, Salel V, Kaghad M and Herbert JM. Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett 1998, 422: 291-295. (Pubitemid 28075481)
8. Ohlmann P, Laugwitz KL, Nurnberg B, Spicher K, Schultz G, Cazenave JP and Gachet C. The human platelet ADP receptor activates Gi2 proteins. Biochem J 1995, 312: 775-779. (Pubitemid 26005987)
9. Jantzen HM, Gousset L, Bhaskar V, Vincent D, Tai A, Reynolds EE and Conley PB. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation. J Thromb Haemost 1999, 81: 111-117. (Pubitemid 29041659)
10. Jin J and Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998, 95: 8070-8074. (Pubitemid 28326067)
11. Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB and Kunapuli SP. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 1998, 273: 2024-2029. (Pubitemid 28069248)
12. Jin J, Daniel JL and Kunapuli SP. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 1998, 273: 2030-2034. (Pubitemid 28069249)
13. Daniel JL, Dangelmaier C, Jin J, Kim YB and Kunapuli SP. Role of intracellular signaling events in ADP-induced platelet aggregation. J Thromb Haemost 1999, 82: 1322-1326. (Pubitemid 29473801)
14. Paul BZ, Jin J and Kunapuli SP. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. J Biol Chem 1999, 274: 29108-29114.
15. Michelson AD. P2Y12 antagonism: promises and challenges. Arterioscler Thromb Vasc Biol 2008, 28: s33-s38.
16. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V and Yang RB, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001, 409: 202-207. (Pubitemid 32144286)
17. Porto I, Giubilato S, De Maria GL, Biasucci LM and Crea F. Platelet P2Y12 receptor inhibition by thienopyridines: status and future. Expert Opin Investig Drugs 2009, 18: 1317-1332.
18. Farid NA, Kurihara A and Wrighton SA. Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. J Clin Pharmacol 2010, 50: 126-142.
19. Husted S. Unmet needs in oral antiplatelet therapy with ADP receptor blocking agents. Fundam Clin Pharmacol 2009, 23: 1-9.
20. Angiolillo DJ and Guzman LA. Clinical overview of promising nonthienopyridine antiplatelet agents. Am Heart J 2008, 156: 23-28.
21. Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov 2010, 9: 154-169.
22. Hillisch A, Pineda LF and Hilgenfeld R. Utility of homology models in the drug discovery process. Drug Discov Today 2004, 9: 659-669. (Pubitemid 38981720)
23. Kitchen DB, Decornez H, Furr JR and Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 2004, 3: 935-949. (Pubitemid 39529931)
24. Zhan C, Yang J, Dong XC and Wang YL. Molecular modeling of purinergic receptor P2Y12 and interaction with its antagonists. J Mol Graph 2007, 26: 20-31. (Pubitemid 46977248)
25. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA and Le Trong I, et al. Crystal structure of rhodopsin: a G-protein-coupled receptor. Science 2000, 289: 739-745. (Pubitemid 30650186)
26. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R and Leslie AG, et al. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008, 454: 486-491.
27. Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ. Basic local alignment search tool. J Mol Biol 1990, 215: 403-410.
28. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY and Pieper U, et al. Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci 2007, S50: 2.9.1-2.9.31.
29. Gouet P, Courcelle E, Stuart DI and Metoz F. ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 1999, 15: 305-308. (Pubitemid 29213756)
30. Laskowski RA, MacArthur MW, Moss DS and Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993, 26: 283-291.
31. DeLano WL and Lam JW. PyMOL: a communications tool for computational models. Abstr Pap Am Chem Soc 2005, 230: 1371-1372.
32. Bender A. DATABASES Compound bioactivities go public. Nat Chem Biol 2010, 6: 309.
33. Kuntz ID, Blaney JM, Oatley SJ, Langridge R and Ferrin TE. A geometric approach to macromolecule-ligand interactions. J Mol Biol 1982, 161: 269-288.
34. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC and Ferrin TE. UCSF chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004, 25: 1605-1612.
35. Schuttelkopf AW and van Aalten DMF. PRODRG: a tool for highthroughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 2004, 60: 1355-1363. (Pubitemid 41079731)
36. Richards FM. Areas, volumes, packing, and protein-structure. Annu Rev Biophys Bioeng 1977, 6: 151-176.
37. Irwin JJ and Shoichet BK. ZINC-a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005, 45: 177-182. (Pubitemid 40736970)
38. Becker OM, Marantz Y, Shacham S, Inbal B, Heifetz A, Kalid O and Bar-Haim S, et al. G protein-coupled receptors: in silico drug discovery in 3D. Proc Natl Acad Sci USA 2004, 101: 11304-11309. (Pubitemid 39038342)
39. Kratochwil NA, Malherbe P, Lindemann L, Ebeling M, Hoener MC, Muhlemann A and Porter RH, et al.. An automated system for the analysis of G protein-coupled receptor transmembrane binding pockets: alignment, receptor-based pharmacophores, and their application. J Chem Inf Model 2005, 45: 1324-1336. (Pubitemid 41476016)
40. Jacob L, Hoffmann B, Stoven V and Vert JP. Virtual screening of GPCRs: an in silico chemogenomics approach. BMC Bioinformatics 2008, 9: 363.
41. Avlani VA, Gregory KJ, Morton CJ, Parker MW, Sexton PM and Christopoulos A. Critical role for the second extracellular loop in the binding of both orthosteric and allosteric G protein-coupled receptor ligands. J Biol Chem 2007, 282: 25677-25686. (Pubitemid 47372845)
42. Cattaneo M, Zighetti ML, Lombardi R, Martinez C, Lecchi A, Conley PB and Ware J, et al. Molecular bases of defective signal transduction in the platelet P2Y(12) receptor of a patient with congenital bleeding. Proc Natl Acad Sci USA 2003, 100: 1978-1983. (Pubitemid 36254559)
43. Mao Y, Zhang L, Jin J, Ashby B and Kunapuli SP. Mutational analysis of residues important for ligand interaction with the human P2Y(12) receptor. Eur J Pharmacol 2010, 644: 10-16.
44. Flower DR. Modelling G-protein-coupled receptors for drug design. Biochim Biophys Acta 1999, 1422: 207-234. (Pubitemid 29512378)
45. Patny A, Desai PV and Avery MA. Homology modeling of G-protein-coupled receptors and implications in drug design. Curr Med Chem 2006, 13: 1667-1691. (Pubitemid 43821698)
46. Reddy Ch S, Vijayasarathy K, Srinivas E, Sastry GM and Sastry GN. Homology modeling of membrane proteins: a critical assessment. Comput Biol Chem 2006, 30: 120-126.
47. Schneider G. Virtual screening: an endless staircase? Nat Rev Drug Discov 2010, 9: 273-276.
48. Shoichet BK. Virtual screening of chemical libraries. Nature 2004, 432: 862-865. (Pubitemid 40037142)
49. Klebe G. Virtual ligand screening: strategies, perspectives and limitations. Drug Discov Today 2006, 11: 580-594.
50. Bissantz C, Bernard P, Hibert M and Rognan D. Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets? Proteins 2003, 50: 5-25. (Pubitemid 36090604)
51. Evers A and Klabunde T. Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor. J Med Chem 2005, 48: 1088-1097. (Pubitemid 40270452)
52. Evers A and Klebe G. Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model. J Med Chem 2004, 47: 5381-5392. (Pubitemid 39382788)
53. Evers A, Hessler G, Matter H and Klabunde T. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols. J Med Chem 2005, 48: 5448-5465. (Pubitemid 41209243)